Repeated body-composition scans may be useful in selected patients, but they are not the only way to monitor muscle health
Any decision to stop or reduce GLP-1 therapy should be made collaboratively with your healthcare team, with appropriate monitoring arrangements in place to safeguard your metabolic health
Triple peptides for the treatment of obesity Retatrutide, a single peptide linked to a fatty diacid moiety, acts as a triple-agonist targeting three receptors: GIP, GLP-1, and glucagon
If you are losing weight steadily at 0.5 mg (20 units, for example), your provider might suggest staying at that dose rather than increasing
You probably know that GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound) have transformed how we treat obesity
Navigating Red Meat and GLP-1s Introduction Starting a weight loss journey with a GLP-1 medication often changes your relationship with food faster than you might expect